MYDGF, myeloid derived growth factor, 56005

N. diseases: 295; N. variants: 3
Disease: Idiopathic Pulmonary Fibrosis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis 		0.040 Biomarker disease BEFREE Treatment targeting IL-25 may be the potential and novel method for IPF patients. 30997832 2019
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis 		0.040 AlteredExpression disease BEFREE IL-25 EBC levels were numerically lowest in IPF (25.33 ± 8.84 pg/ml). 31392802 2019
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis 		0.040 AlteredExpression disease BEFREE In stable patients with IPF over a study period (absolute forced vital capacity (FVC) % of predicted decline/year ≤ 5%, <i>n</i> = 25), a significant decrease in the EBC levels of both IL-25 and TSLP after 12 months of antifibrotic treatment was noted (<i>p</i> < 0.05), whereas, in progressor IPF patients (absolute FVC % of predicted decline/year > 5%, <i>n</i> = 10), a significant decrease was noted in the IL-25 EBC levels only (<i>p</i> < 0.05). 31581688 2019
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis 		0.040 AlteredExpression disease BEFREE IL-25 levels in the BALF were significantly higher in patients with CEP, but not in patients with AEP, than in patients with IPF and sarcoidosis. 28875265 2017